NCT05790252View on ClinicalTrials.gov

Transdermal Patch for BupRenorphine Induction DurinG PrEgnancy (Patch BRIDGE)

PHASE3RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 27, 2023

Primary Completion Date

July 1, 2026

Study Completion Date

December 1, 2026

Conditions
Opioid Use DisorderPregnancy RelatedPregnancy, High RiskPregnancy ComplicationsBuprenorphine Withdrawal
Interventions
DRUG

Buprenorphine Transdermal Matrix Patch

Buprenorphine transdermal patches will be applied at time of induction initiation and removed at 48 hours.

OTHER

Sham patch

Bandage applied at time of induction initiation and removed at 48 hours.

Trial Locations (1)

63124

RECRUITING

Washington University in St. Louis, St Louis

All Listed Sponsors
lead

Washington University School of Medicine

OTHER